Brief: China NT Pharma says co entered into asset purchase agreement with Novartis
18/05/2016 15:39
May 18 (Reuters) - China NT Pharma Group Co Ltd 1011.HK : * NT Pharma (as purchaser) entered into asset purchase agreement with Novartis * Purchase price would be in the aggregate sum of US$145 million * Co has made an application for the resumption of trading in the shares of co with effect from 9:00 a.m. on Thursday, 19 May 2016 * Source text for Eikon ID:nHKS2x01m4 ((For more news, please click here 1011.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on China NT Pharma Co
See all newsBrief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY
Brief: China NT Pharma Makes Application For Resumption Of Trading On Feb 11
Brief: HKEX Says Trading In Shares Of China NT Pharma Group Company Halted
Brief: China Nt Pharma Group Says To Issue Bonds In Aggregate Principal Amount Of HK$65 Million